Entry Detail



General Information

Database ID:exR0080606
RNA Name:RPL37A
RNA Type:mRNA
Chromosome:chr2
Starnd:+
Coordinate:
Start Site(bp):216498825End Site(bp):216579180
External Links:ENSG00000197756



Disease Information

Disease Name:Fragile X Syndrome
Disease Category:Congenital, Hereditary, and Neonatal Diseases and Abnormalities
MeSH ID:D005600
Type:Diseases Category/Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Alias:Fragile X Syndromes//Syndrome, Fragile X//Syndromes, Fragile X//Marker X Syndrome//Marker X Syndromes//Syndrome, Marker X//Syndromes, Marker X//Mental Retardation, X-Linked, Associated With Marxq28//X-Linked Mental Retardation and Macroorchidism//X Linked Mental Retardation and Macroorchidism//Fragile X Mental Retardation Syndrome//Martin-Bell Syndrome//Martin Bell Syndrome//Syndrome, Martin-Bell//Fra(X) Syndrome//FRAXE Syndrome//FRAXE Syndromes//Syndrome, FRAXE//Syndromes, FRAXE//Mental Retardation, X-Linked, Associated With Fragile Site Fraxe//Fragile X-F Mental Retardation Syndrome//Mar (X) Syndrome//FRAXA Syndrome//FRAXA Syndromes//Syndrome, FRAXA//Syndromes, FRAXA



Expression Detail

GEO ID:GSE83556
Description:Global transcriptome dysregulation in second trimester fetuses with FMR1 expansions
Experimental Design:Disease vs Control
Case Disease Type:Fragile X Syndrome
Case Disease SubType:NA
Case Sample:Fragile X Syndrome
Control Sample:Normal
Number of Case:22
Number of Control:18
Number of Samples:40





Regulatory Relationship

mRNA targets:
Gene SymbolChromosomeStart Site(bp)End Site(bp)Strand
AC015813.2
chr17
57989038
58007246
-
AK2
chr1
33007940
33080996
-
AL136295.5
chr14
24147548
24166452
+
AC068547.1
chr2
151802651
151973949
-
ACTN4
chr19
38647649
38731589
+
AC007192.1
chr19
18153158
18178117
+
ADGRL2
chr1
81306160
81992436
+
AC124312.1
chr15
24955034
25000276
+
ACTB
chr7
5527148
5563784
-
AL136295.1
chr14
24189157
24213473
-
AATF
chr17
36948954
37056871
+
AC068580.4
chr11
1734821
1763954
-
AKIRIN1
chr1
38991276
39006059
+
ADPRH
chr3
119579268
119589945
+
AL139011.2
chr1
160216800
160285130
-
AC093827.5
chr4
86886472
86936178
-
ABRACL
chr6
139028745
139043302
+
ABT1
chr6
26596953
26600739
+
ACTR3
chr2
113890063
113962596
+
AC092718.8
chr16
81022316
81096284
-
AKIRIN2
chr6
87674860
87702233
-
AC073508.2
chr17
40627356
40665141
-
ALDH7A1
chr5
126531200
126595362
-
AL133352.1
chr10
100505628
100529881
-
AL049844.3
chr6
143857318
143938471
+
ADD1
chr4
2843857
2930076
+
ADAMTS3
chr4
72280969
72569221
-
AC092718.3
chr16
81053587
81096296
-
ADAL
chr15
43330657
43354555
+
ABCE1
chr4
145098288
145129524
+
miRNA targets:
miRNA SymbolChromosomeStart Site(bp)End Site(bp)Strand
hsa-miR-155-5p
chr21
25573983
25574006
+
hsa-miR-155-3p
chr21
25574022
25574043
+
circRNA targets:NA
lncRNA targets:
lncRNA SymbolChromosomeStart Site(bp)End Site(bp)Strand
AC010729.1
chr2
5726253
5730355
+
AC016747.4
chr2
61115787
61164825
+
AC016876.2
chr17
7581964
7584086
-
AC020978.7
chr16
68224713
68227734
+
AC023509.1
chr12
53441741
53467528
+
AC040934.1
chr17
47409322
47423526
-
AC073321.1
chr2
216594359
216611206
+
AC093827.4
chr4
86924630
86936202
-
AC105105.1
chr18
58535415
58538552
+
AC106739.1
chr16
27313387
27314101
-
AL096870.2
chr14
24209646
24215987
-
Display:



Experiment Detail

GEO ID:GSE83556
Sample Source:Amniotic Fluid
Source Fraction:Supernatant
Platform:GPL570
Method:Microarray
Num of detected RNA Type:1
Num of detected RNAs of this Type:17063
Sample treatment protocol:RNA was extracted from 5-15 mL amniotic fluid supernatant (centrifugation at 350g, 4C, 10, min).
RNA Extract protocol:All samples were processed using the Qiagen Circulating Nucleic Acid kit with an on-column DNase digestion step to remove genomic DNA. The RNA was then purified and concentrated with the RNeasy MinElute Clean up kit and eluted in RNasefree water.
RNA library preparation protocol:RNA was converted to cDNA and amplified using the Ovation Pico WTA kit V2 and then purified with the QIAquick PCR Purification kit. Samples were labeled using the Encore Biotin Module (NuGEN, San Carlos, CA)Samples were labeled using the Encore Biotin Module (NuGEN, San Carlos, CA).



Reference

PMID:NA
Title:NA
Author:NA
Journal:NA
Description:NA